4.8 Article

Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing

Journal

NUCLEIC ACIDS RESEARCH
Volume 37, Issue 19, Pages 6515-6527

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkp633

Keywords

-

Funding

  1. Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan
  2. National Institute of Biomedical Innovation (NIBI)
  3. Japanese Ministry of Education, Global Center of Excellence (GCOE)
  4. International Research Center for Molecular Science in Tooth and Bone Diseases
  5. Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF)

Ask authors/readers for more resources

Viruses use alternative splicing to produce a broad series of proteins from small genomes by utilizing the cellular splicing machinery. Since viruses use cellular RNA binding proteins for viral RNA processing, it is presumable that the splicing of cellular pre-mRNAs is affected by viral infection. Here, we showed that herpes simplex virus type 2 (HSV-2) modifies the expression of promyelocytic leukemia (PML) isoforms by altering pre-mRNA splicing. Using a newly developed virus-sensitive splicing reporter, we identified the viral protein ICP27 as an alternative splicing regulator of PML isoforms. ICP27 was found to bind preferentially to PML pre-mRNA and directly inhibit the removal of PML intron 7a in vitro. Moreover, we demonstrated that ICP27 functions as a splicing silencer at the 3' splice site of the PML intron 7a. The switching of PML isoform from PML-II to PML-V as induced by ICP27 affected HSV-2 replication, suggesting that the viral protein modulates the splicing code of cellular pre-mRNA(s) governing virus propagation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available